IDIA.SW(IDIA.SW)
IDIA.SW
New analysis of Idorsia’s aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension
Santhera schlägt Dr. Srishti Gupta als neues Mitglied des Verwaltungsrats
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
Idorsia’s daridorexant delivers outstanding results in a Phase 2 study in children with insomnia disorder
Clear route to registration positions lucerastat as the potential first oral therapy for all patients with Fabry disease
Idorsia's treatment for insomnia disorder wins the inaugural Prix Galien Bridges Award in the ‘Best Biotechnology & Pharmaceutical Product' category